90% of pancreatic and NSCLC cancers have 10- to 100-fold of elevated levels of NQO1, and 60% of breast, prostate and colon cancers overexpress NQO1 5- to 20- fold [5–7]. Here, NQO1 is linked to malignant colon neoplasm.